For providers, those findings point to a clear opportunity: GLP-1 medication can help patients lose weight, but structured behavioral support may help them protect that progress when treatment changes or ends
Surgery may be the better fit if your goal is to reduce or eliminate long-term prescriptions not just for weight loss, but for related conditions like diabetes or hypertension
If retatrutide caused disproportionate muscle loss compared to other GLP-1 medications, that would be a genuine concern
The role of hypothalamic mammalian target of rapamycin complex 1 signaling in diet-induced obesity
Transport of L-carnitine in human corneal and conjunctival epithelial cells
Poniedziaek, B., Siwulski, M., Wiater, A., Komaniecka, I., Komosa, A., Gsecka, M., Magdziak, Z., Mleczek, M., Niedzielski, P., Proch, J., Ropacka-Lesiak, M., Lesiak, M., Henao, E., & Rzymski, P